|Description||Generic Pharmaceutical Company|
|Venture Round, 3/2012 ||$5.71M|
|Series B, 12/2013 |
JW Asset Management
As a rapidly emerging generic pharmaceutical company, Vensun has filed several Abbreviated New Drug Applications (ANDAs) with the FDA through its partnerships and currently has over 30 products in active development. We are actively seeking additional opportunities for partnerships, strategic alliances, and product acquisitions to enhance our existing development portfolio.